These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 29017963)

  • 1. The role of CXCL12 in tumor microenvironment.
    Meng W; Xue S; Chen Y
    Gene; 2018 Jan; 641():105-110. PubMed ID: 29017963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.
    Guo F; Wang Y; Liu J; Mok SC; Xue F; Zhang W
    Oncogene; 2016 Feb; 35(7):816-26. PubMed ID: 25961926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.
    Scala S
    Clin Cancer Res; 2015 Oct; 21(19):4278-85. PubMed ID: 26199389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on CXCR4/CXCL12 axis in oncology: no place to hide.
    Domanska UM; Kruizinga RC; Nagengast WB; Timmer-Bosscha H; Huls G; de Vries EG; Walenkamp AM
    Eur J Cancer; 2013 Jan; 49(1):219-30. PubMed ID: 22683307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis.
    Shi J; Wei Y; Xia J; Wang S; Wu J; Chen F; Huang G; Chen J
    Future Oncol; 2014 Apr; 10(5):749-59. PubMed ID: 24799056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis.
    Mortezaee K
    Life Sci; 2020 May; 249():117534. PubMed ID: 32156548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting SDF-1 in multiple myeloma tumor microenvironment.
    Bouyssou JM; Ghobrial IM; Roccaro AM
    Cancer Lett; 2016 Sep; 380(1):315-8. PubMed ID: 26655999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy.
    Zhou Y; Cao HB; Li WJ; Zhao L
    Chin J Nat Med; 2018 Nov; 16(11):801-810. PubMed ID: 30502762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer.
    Wu PF; Lu ZP; Cai BB; Tian L; Zou C; Jiang KR; Miao Y
    Chin Med J (Engl); 2013; 126(17):3371-4. PubMed ID: 24033967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 Ligands: The Next Big Hit?
    Walenkamp AME; Lapa C; Herrmann K; Wester HJ
    J Nucl Med; 2017 Sep; 58(Suppl 2):77S-82S. PubMed ID: 28864616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L; Tavano F; Morelli F; Latiano TP; Di Sebastiano P; Maiello E
    Crit Rev Oncol Hematol; 2013 Dec; 88(3):696-705. PubMed ID: 24120239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of chemokine CXCL12 and its receptor to tumor metastasis].
    Jiang YP; Wu XH
    Ai Zheng; 2007 Feb; 26(2):220-4. PubMed ID: 17298758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
    Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
    Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
    Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
    J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CXCL12-CXCR4 Signaling Axis Plays a Key Role in Cancer Metastasis and is a Potential Target for Developing Novel Therapeutics against Metastatic Cancer.
    Yang P; Hu Y; Zhou Q
    Curr Med Chem; 2020; 27(33):5543-5561. PubMed ID: 31724498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 receptor as a promising target for oncolytic drugs.
    Lavrovsky Y; Ivanenkov YA; Balakin KV; Medvedeva DA; Ivachtchenko AV
    Mini Rev Med Chem; 2008 Oct; 8(11):1075-87. PubMed ID: 18855724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection.
    Patrussi L; Baldari CT
    Curr Med Chem; 2011; 18(4):497-512. PubMed ID: 21143114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it possible to treat melanoma by intercepting the CXCR4/CXCL12 pathway?
    Motlak M; Mathews M; Al-Odat OS; Pandey MK
    Cytokine; 2024 Jul; 179():156629. PubMed ID: 38704961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy.
    Mousavi A
    Immunol Lett; 2020 Jan; 217():91-115. PubMed ID: 31747563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
    Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
    Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.